HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) CME: Take the course for this article: Paradigms for Primary Prevention of Ovarian Carcinoma Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barnes, M. N. Articles by Partridge, E. E. Search for Related Content PubMed PubMed Citation Articles by Barnes, M. N. Articles by Partridge, E. E.

Paradigms for Primary Prevention of Ovarian Carcinoma

Dr. Barnes is Assistant Professor, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL.
Dr. Grizzle is Professor, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL.
Dr. Grubbs is Professor, Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL.
Dr. Partridge is Professor, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL.

Objective: To provide the clinician with current concepts regarding prevention of ovarian cancer. Specifically, in this review, we provide a rationale for chemoprevention of ovarian cancer, a description of promising chemopreventive agents, and an overview of surgical strategies used in the prevention of ovarian cancer.

Data Sources: A computerized search of articles published through December 2001 was performed using the MEDLINE database from the period of 1966 to present. Search terms utilized included ovarian neoplasms, primary prevention, chemoprevention, oral contraceptives, NSAIDs, retinoids, ovariectomy, and tubal sterilization. Additional sources were identified through cross-referencing.

Methods of Study Selection: All identified references relevant to prevention of ovarian carcinoma were reviewed.

Tabulation, Integration, and Results: Each reference was reviewed to determine the relevant contribution to the fundamental science of ovarian cancer prevention. Particular attention was paid to those studies that offered insight into the development of translational trials in ovarian cancer chemoprevention.

Conclusions: Investigation into chemoprevention for ovarian cancer represents a vastly underdeveloped area of research. Continued research efforts toward identification of novel compounds will accelerate the progress of clinical trials in this neglected area of investigation.

This article has been cited by other articles:

				D. Wang, Z. Zhao, A. Caperell-Grant, G. Yang, S. C. Mok, J. Liu, R. M. Bigsby, and Y. Xu S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells Mol. Cancer Ther., July 1, 2008; 7(7): 1993 - 2002. [Abstract] [Full Text] [PDF]

				A. Banzato, S. Bobisse, M. Rondina, D. Renier, F. Bettella, G. Esposito, L. Quintieri, L. Melendez-Alafort, U. Mazzi, P. Zanovello, et al. A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent In vivo Therapeutic Activity Clin. Cancer Res., June 1, 2008; 14(11): 3598 - 3606. [Abstract] [Full Text] [PDF]

				J. M. Saucier, J. Yu, A. Gaikwad, R. L. Coleman, J. K. Wolf, and J. A. Smith Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model Journal of Oncology Pharmacy Practice, March 1, 2007; 13(1): 39 - 45. [Abstract] [PDF]

				G. Xu, H. Zhou, Q. Wang, N. Auersperg, and C. Peng Activin Receptor-Like Kinase 7 Induces Apoptosis through Up-Regulation of Bax and Down-Regulation of Xiap in Normal and Malignant Ovarian Epithelial Cell Lines Mol. Cancer Res., April 1, 2006; 4(4): 235 - 246. [Abstract] [Full Text] [PDF]

				G. Xu, Y. Zhong, S. Munir, B. B. Yang, B. K. Tsang, and C. Peng Nodal Induces Apoptosis and Inhibits Proliferation in Human Epithelial Ovarian Cancer Cells via Activin Receptor-Like Kinase 7 J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5523 - 5534. [Abstract] [Full Text] [PDF]

				M. Navo and J. A. Smith Update on the Prevention and Treatment of Ovarian Cancer Journal of Pharmacy Practice, June 1, 2003; 16(3): 149 - 156. [Abstract] [PDF]

				D. Cvetkovic, S. J. Williams, and T. C. Hamilton Loss of Cellular Retinol-binding Protein 1 Gene Expression in Microdissected Human Ovarian Cancer Clin. Cancer Res., March 1, 2003; 9(3): 1013 - 1020. [Abstract] [Full Text] [PDF]